BioGeometry
Latest round
- Series A
Last raised
- Oct 2026
Total raised
- $110M
Investors
- 13
About BioGeometry
, trading as BioGeometry, is a digital biotechnology company that specializes in applying generative AI to protein design. The company's founder, Dr. Jian Tang, is an associate professor at the Institute of Algorithms at the University of Montreal, Canada, and was a researcher at Microsoft Research Asia. The company also has partanerships with Nvidia, Intel, IBM and other companies. The company builds TorchDrug, an open source machine learning system mainly for small molecule drug development, and TorchProtein, an open source platform for large molecule drug development, and is committed to accelerating the process of drug development through AI. The company has also built GeoFlow, a generative AI protein design macromodel that can be used for both antigen-antibody complex structure prediction and antibody design tasks. Based on this big model, the company has developed the GeoBiologics one-stop protein design platform. The company generates revenue by providing AI-driven protein design services and licensing its proprietary platforms to pharmaceutical and biotechnology firms.
Who invested in BioGeometry
13 investors across 3 rounds
See all investors in BioGeometry
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioGeometry
Who invested in BioGeometry?
BioGeometry has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioGeometry raised?
BioGeometry has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BioGeometry last raise money?
BioGeometry's most recent round on record is a Series A, in Oct 2026.
What does BioGeometry do?
, trading as BioGeometry, is a digital biotechnology company that specializes in applying generative AI to protein design.
Where is BioGeometry headquartered?
BioGeometry is headquartered in Beijing, China.
Which VCs invest in companies like BioGeometry?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BioGeometry's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioGeometry? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.